Loading…
Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies
In this study, the inhibition potential of 3- and 4-arylcoumarin derivatives on Theileria annulata enolase ( Ta ENO) was assessed for the first time in the literature. Firstly, protein stabilization analyses of Ta ENO were performed and it was found that the enzyme remains stable with the addition o...
Saved in:
Published in: | Molecular diversity 2020-11, Vol.24 (4), p.1149-1164 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this study, the inhibition potential of 3- and 4-arylcoumarin derivatives on
Theileria annulata
enolase (
Ta
ENO) was assessed for the first time in the literature. Firstly, protein stabilization analyses of
Ta
ENO were performed and it was found that the enzyme remains stable with the addition of 6 M ethylene glycol at + 4 °C. Inhibitor screening analyses were carried out using 25 coumarin derivatives on highly purified
Ta
ENO (> 95%), and four coumarin derivatives [4-(3,4-dimethoxyphenyl)-6,7-dihydroxy-2H-chromen-2-one (C8); 4-(3,4-dihydroxyphenyl)-7,8 dihydroxy-2H-chromen-2-one (C9); 4-(3,4-dihydroxyphenyl)-6,7-dihydroxy-2H-chromen-2 one (C21); and 3-(3,4-dihydroxyphenyl)-7,8-dihydroxy-2H-chromen-2-one (C23)] showed the highest inhibitory effects with the IC
50
values of 10.450, 13.170, 8.871 and 10.863 µM, respectively. The kinetic results indicated that these compounds inhibited the enzyme by uncompetitive inhibition. In addition, the successful binding of the most potent inhibitor (C21) into
Ta
ENO was confirmed by using MALDI-TOF mass spectrophotometry. Molecular docking analyses have predicted that C8 and C21 coumarin derivatives which showed high inhibitory effects on
Ta
ENO were interacted with high affinity to the potential regions out of the active site. Taken together, these coumarin derivatives (C8, C9, C21 and C23) are first known potent, nonsubstrate, uncompetitive inhibitors of
Ta
ENO and these results will facilitate further in vitro and in vivo analysis toward structure-based drug design studies.
Graphic abstract |
---|---|
ISSN: | 1381-1991 1573-501X |
DOI: | 10.1007/s11030-019-10018-9 |